BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21364590)

  • 21. MiR-10b inhibits migration and invasion of pancreatic ductal adenocarcinoma via regulating E2F7.
    Xu C; Qi X
    J Clin Lab Anal; 2020 Oct; 34(10):e23442. PubMed ID: 32592206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions.
    Kolb A; Kleeff J; Guweidhi A; Esposito I; Giese NA; Adwan H; Giese T; Büchler MW; Berger MR; Friess H
    Cancer Biol Ther; 2005 Jul; 4(7):740-6. PubMed ID: 15970685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer: A study based on TCGA and tissue microarray.
    Hu H; Wu LL; Han T; Zhuo M; Lei W; Cui JJ; Jiao F; Wang LW
    Oncotarget; 2017 May; 8(20):33265-33275. PubMed ID: 28402278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2.
    Zhang Z; Che X; Yang N; Bai Z; Wu Y; Zhao L; Pei H
    Biomed Pharmacother; 2017 Dec; 96():1341-1348. PubMed ID: 29196101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
    Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C
    J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
    Martínez-Fernández P; Hierro L; Jara P; Alvarez L
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma.
    Ye Y; Chen J; Zhou Y; Fu Z; Zhou Q; Wang Y; Gao W; Zheng S; Zhao X; Chen T; Chen R
    J Transl Med; 2015 Apr; 13():137. PubMed ID: 25925763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profiling in lymph node-positive and lymph node-negative pancreatic cancer.
    Kim HN; Choi DW; Lee KT; Lee JK; Heo JS; Choi SH; Paik SW; Rhee JC; Lowe AW
    Pancreas; 2007 Apr; 34(3):325-34. PubMed ID: 17414055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target.
    Koorstra JB; Karikari CA; Feldmann G; Bisht S; Rojas PL; Offerhaus GJ; Alvarez H; Maitra A
    Cancer Biol Ther; 2009 Apr; 8(7):618-26. PubMed ID: 19252414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fucosyltransferase 8 plays a crucial role in the invasion and metastasis of pancreatic ductal adenocarcinoma.
    Tada K; Ohta M; Hidano S; Watanabe K; Hirashita T; Oshima Y; Fujnaga A; Nakanuma H; Masuda T; Endo Y; Takeuchi Y; Iwashita Y; Kobayashi T; Inomata M
    Surg Today; 2020 Jul; 50(7):767-777. PubMed ID: 31950256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
    Meng F; Li W; Li C; Gao Z; Guo K; Song S
    Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
    Xia X; Zhang K; Cen G; Jiang T; Cao J; Huang K; Huang C; Zhao Q; Qiu Z
    Oncotarget; 2015 Aug; 6(25):21046-63. PubMed ID: 26019136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Src-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis.
    Peng Z; Raufman JP; Xie G
    PLoS One; 2012; 7(10):e48461. PubMed ID: 23119029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b.
    Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X
    J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-132 promotes the proliferation, invasion and migration of human pancreatic carcinoma by inhibition of the tumor suppressor gene PTEN.
    Zhang H; Liu A; Feng X; Tian L; Bo W; Wang H; Hu Y
    Prog Biophys Mol Biol; 2019 Nov; 148():65-72. PubMed ID: 28941804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
    Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
    Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
    Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
    Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLCγ.
    Zhang X; Shi G; Gao F; Liu P; Wang H; Tan X
    Oncol Rep; 2019 Apr; 41(4):2117-2125. PubMed ID: 30720116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition.
    Lv B; Ma L; Tang W; Huang P; Yang B; Wang L; Chen S; Gao Q; Zhang S; Xia J
    Cell Physiol Biochem; 2018; 48(1):158-172. PubMed ID: 30001540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.